Pharmacological Reviews

Papers
(The H4-Index of Pharmacological Reviews is 44. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Innovative therapeutics for renoprotection: Where we are433
Seventy-Five Years of Interactions: The Department of Physiology and Pharmacology at Karolinska Institutet and Pharmacological Reviews426
The Role of G Protein–Coupled Receptors and Receptor Kinases in Pancreatic β-Cell Function and Diabetes259
The Nitrogen Mustards205
Reimagining pharmacology education187
The Myc Family and the Metastasis Suppressor NDRG1: Targeting Key Molecular Interactions with Innovative Therapeutics161
Review of Natural Language Processing in Pharmacology152
Therapeutic advantage of combinatorial chimeric antigen receptor T cell and chemotherapies138
Table of Contents124
Metal-based antibody, nanobody, and peptide conjugates: Potential for breast cancer therapy123
Table of Contents123
Carbonic anhydrase inhibitors: “Old” drugs with new potential in unexpected areas115
The endocannabinoidomes: Pharmacological redundancy and promiscuity, and multi-kingdom variety of sources and molecular targets110
Table of Contents109
International Union of Basic and Clinical Pharmacology CXIII: Nuclear Receptor Superfamily—Update 2023102
Pharmaceutical perspectives on oligonucleotide therapeutics and delivery systems102
Pharmacology and therapeutics of bile acid synthesis and modification enzymes in metabolic diseases90
Optical Approaches for Investigating Neuromodulation and G Protein–Coupled Receptor Signaling84
Elucidating the Interactome of G Protein-Coupled Receptors and Receptor Activity-Modifying Proteins79
Innovation in cancer pharmacotherapy through integrative consideration of germline and tumor genomes79
Pharmacological Modulation of the Crosstalk between Aberrant Janus Kinase Signaling and Epigenetic Modifiers of the Histone Deacetylase Family to Treat Cancer73
Targeting of kinases to treat neurodegenerative diseases70
Table of Contents69
G Protein-Coupled Receptor Pharmacology—Insights from Mass Spectrometry67
Asthma therapeutics: Past, present, and future66
miR-155 aberrant expression impairs tumor rejection because of its targeting of ICOSL and multiple pathways implicated in the antitumor response61
Therapeutic Potential of Targeting Prokineticin Receptors in Diseases60
Roles of Individual Human Cytochrome P450 Enzymes in Drug Metabolism60
The Hippo pathway: Organ size control and beyond60
Carbon Monoxide Signaling: Examining Its Engagement with Various Molecular Targets in the Context of Binding Affinity, Concentration, and Biologic Response60
Molecular Tweezers: Supramolecular Hosts with Broad-Spectrum Biological Applications57
Sulfotransferase 2B1b, Sterol Sulfonation, and Disease56
Corrigendum to “International Union of Basic and Clinical Pharmacology. CXIX. Fundamental insights and clinical relevance regarding the carnitine palmitoyltransferase family of enzymes” [Pharmacologic56
From neuroimmune circuits to targeted therapy of chronic pruritus54
Targeting Persistent Changes in Neuroimmune and Epigenetic Signaling in Adolescent Drinking to Treat Alcohol Use Disorder in Adulthood52
Nonhormonal Male Contraceptive Development—Strategies for Progress52
Opportunities for Nitric Oxide in Potentiating Cancer Immunotherapy51
Disulfidptosis: A novel cell death mechanism with pathological significance and therapeutic potential in diseases51
Neurobiology of the incubation of drug craving: An update51
Dopamine, Immunity, and Disease49
Pharmacological Reviews’ 75th Year Anniversary: Past and Future—Editorial49
Editorial Board49
Extracellular Vesicle Heterogeneity and Its Impact for Regenerative Medicine Applications47
Effects of Medications on Heat Loss Capacity in Chronic Disease Patients: Health Implications Amidst Global Warming47
International Union of Basic and Clinical Pharmacology xxx: Applying an objective evaluation to the status of Class A orphan G protein-coupled receptors44
Animal Behavior in Psychedelic Research44
0.21413898468018